An insidious interloper now often comes between me and my patients. I’m talking about pharmacy benefit managers (PBMs), the middlemen that have introduced a bureaucratic and nightmarish system of delays and denials into filling prescriptions.
At the Community Oncology Alliance (COA) Annual Meeting (April 4-5, 2019; Orlando, FL), Journal of Clinical Pathways sat down with three of the leaders of OneOncology – a new partnership of independent community oncology practices that is physician-driven and utilizes a unified platform to enable physicians to care for patients through the entire course of care.
COA Applauds the Senate Finance Committee for PBM Hearing as Part of National Efforts to Shed Light on PBM Abuses and Lower Drug Prices
More Investigation and Oversight Needed to Examine Adverse Impact of PBM Abuses on Patient Care
Statement from Ted Okon executive director of the Community Oncology Alliance